Medic Now

medicnow.com

Medic Now is the UK's leading recruitment agency for ambulance professionals. We enable Paramedics, IHCD Technicians, Emergency Care Assistants and PTS attendants to work on a flexible, locum basis within the industry. We are partnered with several NHS and private organisations throughout the UK; offering a sophisticated staffing solution for our clients with qualified and compliant pre-hospital professional's.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

ENTERPRISE THERAPEUTICS NABS NOVARTIS VC EXEC AS NEW CMO

FierceBiotech | February 10, 2020

news image

Britain-based biotech Enterprise Therapeutics has hired Novartis Venture Fund managing director David Morris, M.D., as its next chief medical officer. Morris, who will continue to serve as the fund’s operating partner, will lead Enterprise’s development strategy and drive its two lead respiratory programs through the clinic. These are ETD002, a first-in-class TMEM16A potentiator, and ETD001, an ENaC blocker, both of which are hoping to help cystic fibrosis (CF) patients....

Read More

Cell and Gene Therapy

PACBIO ACQUIRES OMNIOME, A DNA SEQUENCING STARTUP, FOR UP TO $800 MILLION

PacBio | July 26, 2021

news image

Pacific Biosciences has had no trouble growing its business on its own in the year and a half since its acquisition by Illumina was blocked by the Federal Trade Commission due to concerns that the combination would establish a monopoly in DNA sequencing. Earlier this year, the sequencer manufacturer received a staggering $900 million investment from SoftBank—a commitment almost as large as the $1.2 billion promised by Illumina for the planned acquisition. PacB...

Read More

Medical

FAUNA BIO'S COMPARATIVE GENOMICS APPROACH FINDS NEW COMPOUNDS FOR HEART AND LUNG DISEASES

Fauna | June 15, 2022

news image

Fauna Bio, a biotechnology company pioneering the fields of comparative, computational and translational genomics, is celebrating its fourth birthday this month with the release of Centaur, a knowledge graph that is the first of its kind to visualize the intersection between animal gene expression data and human diseases in one comprehensive map. With Centaur, Fauna Bio is able to more rapidly identify human disease indications and targets to generate new therapeutic solutions for some of the mo...

Read More

Cell and Gene Therapy

VAXART ANNOUNCES HIGHLY REGARDED BIOTECH EXECUTIVE ELAINE J. HERON, PH.D. JOINS BOARD OF DIRECTORS

Vaxart, Inc. | August 29, 2022

news image

Vaxart, Inc. announced that Elaine J. Heron, Ph.D. was appointed to the Company’s Board of Directors, effective August 25, 2022. "Elaine has tremendous experience in life science research and development, sales and marketing, finance, and accounting, as well as corporate governance matters,” said Andrei Floroiu, Vaxart's Chief Executive Officer. "We welcome Elaine to Vaxart and the Board.” The Company also announced that Dr. Julie Che...

Read More
news image

ENTERPRISE THERAPEUTICS NABS NOVARTIS VC EXEC AS NEW CMO

FierceBiotech | February 10, 2020

Britain-based biotech Enterprise Therapeutics has hired Novartis Venture Fund managing director David Morris, M.D., as its next chief medical officer. Morris, who will continue to serve as the fund’s operating partner, will lead Enterprise’s development strategy and drive its two lead respiratory programs through the clinic. These are ETD002, a first-in-class TMEM16A potentiator, and ETD001, an ENaC blocker, both of which are hoping to help cystic fibrosis (CF) patients....

Read More
news image

Cell and Gene Therapy

PACBIO ACQUIRES OMNIOME, A DNA SEQUENCING STARTUP, FOR UP TO $800 MILLION

PacBio | July 26, 2021

Pacific Biosciences has had no trouble growing its business on its own in the year and a half since its acquisition by Illumina was blocked by the Federal Trade Commission due to concerns that the combination would establish a monopoly in DNA sequencing. Earlier this year, the sequencer manufacturer received a staggering $900 million investment from SoftBank—a commitment almost as large as the $1.2 billion promised by Illumina for the planned acquisition. PacB...

Read More
news image

Medical

FAUNA BIO'S COMPARATIVE GENOMICS APPROACH FINDS NEW COMPOUNDS FOR HEART AND LUNG DISEASES

Fauna | June 15, 2022

Fauna Bio, a biotechnology company pioneering the fields of comparative, computational and translational genomics, is celebrating its fourth birthday this month with the release of Centaur, a knowledge graph that is the first of its kind to visualize the intersection between animal gene expression data and human diseases in one comprehensive map. With Centaur, Fauna Bio is able to more rapidly identify human disease indications and targets to generate new therapeutic solutions for some of the mo...

Read More
news image

Cell and Gene Therapy

VAXART ANNOUNCES HIGHLY REGARDED BIOTECH EXECUTIVE ELAINE J. HERON, PH.D. JOINS BOARD OF DIRECTORS

Vaxart, Inc. | August 29, 2022

Vaxart, Inc. announced that Elaine J. Heron, Ph.D. was appointed to the Company’s Board of Directors, effective August 25, 2022. "Elaine has tremendous experience in life science research and development, sales and marketing, finance, and accounting, as well as corporate governance matters,” said Andrei Floroiu, Vaxart's Chief Executive Officer. "We welcome Elaine to Vaxart and the Board.” The Company also announced that Dr. Julie Che...

Read More